ENDOCRINE PHARM REVIEW Flashcards

(45 cards)

1
Q

Desmopressin

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Desmopressin

Central Diabetes Insipidus. Also used diagnostically

Recombinant AVP; stimulates V2R

-

Can be given IV/SC/PO, usually twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Conivaptan/Talvaptan

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Conivaptan/Talvaptan

SIADH management

Blocks V2R to reduce AQ2 translocation.

Rare association with liver failure

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Demeclocycline

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Demeclocycline

SIADH management

Inhibits the collecting tubules response to AVP

Nephrotoxic (rarely used)

Takes up to one week to be effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hGH

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

hGH

GH deficiency (eg short stature)

Recombinant growth hormone…

Rare: SCFE, scoliosis, pseudotumor cerebri, apnea

Give each evening, subQ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cabergoline

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Cabergoline

Hyperprolactinemia. Adjunct for acromegaly, secondary Cushing’s…

Agonizes dopamine receptors, downregulating prolactin

N/V, orthostatic hypotension, rare cardiac valvulopathy in Parkinson’s patients.

Better half life, affinity, (everything) than bromocriptine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bromocriptine

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Bromocriptine

Hyperprolactinemia (1st trimester pregnancies)

Dopamine agonist, downregulates prolactin

As cabergoline, but generally worse.

Shorter half-life, requires frequent dosing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Octreotide/Lanreotide

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Octreotide/Lanreotide

Acromegaly.

Somatostatin agonist, decreases GH secretion.

Diarrhea, abdominal cramping, flatulence, cholelithiasis.

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pegvisomant

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Pegvisomant

(refractory) Acromegaly.

GH receptor antagonist (mainly at liver)

Transient liver panel elevation, tumor growth

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Megestrol Acetate

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Megestrol Acetate

Cachexia of cancer patients

Progesterone compound, suppresses ACTH and cortisol. Stimulates appetite, apparently.

-

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mifepristone

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Mifepristone

Primary Cushing’s disease

Glucocorticoid receptor antagonist. (Note: may precipitate adrenal insufficiency)

-

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hydrocortisone

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Hydrocortisone

Primary > secondary adrenal insufficiencies.

Exogenous glucocorticoid…

See Cushing’s syndrome.

Can be given orally (daily). Give IM/IV in acute crisis or pre-op.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fludrocortisone

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Fludrocortisone

Primary (not secondary!) adrenal insufficiency.

Exogenous mineralocorticoid…

See hyperaldosteronism

Take daily, monitor plasma renin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pasireotide

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Pasireotide

Secondary Cushing’s syndrome (refractory to surgery)

Somatostatin analog; reduces ACTH secretion.

Numerous side effects: diarrhea, nausea, hyperglycemia, headache…

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ketoconazole

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Ketoconazole

Primary Cushing’s syndrome

Adrenal steroidogenesis inhibitor

Liver toxicity

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Metyrapone

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Metyrapone

Primary Cushing’s syndrome

Adrenal steroidogenesis inhibitor (11-beta hydroxylase inhibitor)

-

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mitotane

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Mitotane

Primary Cushing’s diseease (due to carcinoma)

Adrenal steroidogenesis inhibitor, lytic in high doses.

-

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Etomidate

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Etomidate

Primary Cushing’s disease (especially in critically ill)

Adrenal steroidogenesis inhibitor

-

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Spironolactone & Eplerenone

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Spironolactone & Eplerenone

Primary hyperaldosteronism.

Mineralocorticoid receptor antagonists.

Hyperkalemia…

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Amiloride & Triamterene

Indication?

Mechanism of action?

Side effects / contraindications?

Kinetic considerations?

A

Amiloride & Triamterene

Liddle’s syndrome

Blocks the ENaC channel (downstream of spirono/eplerenone)

-

-

20
Q

Phenoxybenzamine

Indication?

Mechanism of action?

Side effects & contraindications?

Kinetic considerations?

A

Phenoxybenzamine

Pheochromocytoma, notably pre-operatively.

Irreversibly blocks alpha receptors.

Orthostatic hypotension (a good goal for pre-op)

-

21
Q

Calcitonin

Indication?

Mechanism of action?

Side effects & contraindications?

Kinetic considerations?

A

Calcitonin

Treatment of hypercalcemia, osteomalacia, Paget’s disease…(last resort)

Reduce osteoclast activity (weak!)

-

Tachyphylaxis.

22
Q

Bisphosphonates

Indication?

Mechanism of action?

Side effects & contraindications?

Kinetic considerations?

A

Bisphosphonates

Treatment of hypercalcemia, osteoporosis, osteomalacia, Paget’s…

Induce osteoclast apoptosis by blocking farnesyl synthesis

Esophageal irritation (oral), acute phase reaction, femoral fractures, jaw osteonecrosis.

Ibandronate & Aledronate are oral, Pamedronate and Zanidronic acid are IV (more potent)

23
Q

Cinacalcet

Indication?

Mechanism of action?

Side effects & contraindications?

Kinetic considerations?

A

Cinacalcet

Treatment of hypercalcemia, hyperparathyroidism

Calcimimetic which downregulates PTH production.

-

-

24
Q

Calcium Gluconate

Indication?

Mechanism of action?

Side effects & contraindications?

Kinetic considerations?

A

Calcium Gluconate

Acute hypocalcemia.

Just replacement calcium…

-

Given IV.

25
**Denosumab** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Denosumab** Osteomalacia & Paget's disease Monoclonal antibody that targets RANK-L to reduce osteoclast differentation. Nausea, fatigue, increased risk of skin infections. -
26
**Raloxifene** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Raloxifene** Prevention of fractures in osteoporotic patients. Maybe breast cancer. SERM Some increased thrombotic risk -
27
**Teriparatide** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Teriparatide** Bone anabolism (eg Osteomalacia, osteoporosis) PTH analog, promotes osteoblasts if given intermittently. Transient hypercalcemia, hypercalciuria Given constantly, will stimulate osteoclasts instead.
28
**Levothyroxine** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Levothyroxine** Hypothyroidism Replacement T4. Chemically identical to endogenous product! No reported side effects. Give once a day, but half life is about a week.
29
**Liothyronine** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Liothyronine** Hypothyroidism; more acute than levothyroxine (eg Myxedema coma?) Replacement T3, chemically indistinguishable. - Shorter lasting than T4, needs more frequent dosing.
30
**Methimazole** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Methimazole** Hyperthyroidism. Inhibits iodide oxidation. Some lupus-like symptoms, and reversible agranulocytosis. -
31
**Propylthiouracil** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Propylthiouracil** Hyperthyroidism in early pregnancy. Blocks iodine oxidation, as well as peripheral deiodination to T3. Lupus-like symptoms, reversible agranulocytosis, hepatic failure. -
32
**Iodide** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Iodide** Hyperthyroidism, pre-op for thyroidectomy, and for radioactive fallout treatment. Reduces thyroid iodine uptake (Wolf-Chaikoff effect). Shrinks and reduces vascularity of thyroid. Acute sensitivity (angioedema, laryngeal edema, serum sickness), head cold.
33
**131I** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**131I** Thyroid ablation (not medullary carcinomas!) Deposits in colloid, produces beta/gamma radiation. Hypothyroidism (lol) -
34
**Cholestyramine** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Cholestyramine** Hyperthyroidisim Binds and removes thyroid hormone from enterohepatic circulation. - -
35
**Beta-blockers** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Beta-blockers** Mild hyperthyroidism, pre-op pheochromocytoma Block adrenergic effects of thyroid/pheochromocytoma - -
36
**Exogenous Insulins** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Exogenous Insulins** Type 1 DM, some Type 2 DM. Replaces deficient insulin production. Downregulates gluconeogenesis, glycogenolysis, glucagon, and lipolysis. Hypoglycemia, allergy, lipoatrophy/hypertrophy, weight gain, edema, "cancer & atherosclerosis" Wide range of insulins & regimens to choose from.
37
**Sulfonylureas** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Sulfonylureas** Type 2 DM. Stimulate potassium ATPase in pancreatic beta cells to depolarize and release more insulin. Hyponatremia, disulfiram-like reactions, usual stuff, hypoglycemia.
38
**Metformin** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Metformin** Type 2 DM. Sensitizes the liver to insulin (mainly reduces GNG) GI effects, lactic acidosis. Worse with renal insufficiency, old age, CHF, hypoxia, acute illness, drinking & liver disease. -
39
**Thiazolidinediones** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Thiazolidinediones** Type 2 DM. Sensitize peripheral tissues to insulin by PPAR receptor agonism. Liver toxicity (troglitazone), weight gain, fluid retention (pedal). CVD mortality (rosiglitazone), bladder cancer. -
40
**GLP-1 Analogs** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**GLP-1 Analogs** Type 2 DM. Incretin; increases insulin secretion, beta cell mass, weight loss. Inhibits glucagon. Mostly GI, headaches, pancreatitis. Long-lasting, given as SQ (eg Exenatide, liraglutide)
41
**DPP-4 Inhibitors** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**DPP-4 Inhibitors** Type 2 DM. Prolong GLP-1, see incretin effects. Presumably same as GLP-1 analogs; NVD, headaches, pancreatitis. Given ORALLY.
42
**SGTP-2 Inhibitors** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**SGTP-2 Inhibitors** Type 2 (and 1?) DM. Increase glucose excretion by blocking sodium-linked transporter in proximal tubule. Yeast infections, dehydration. -
43
**Alpha-glucosidase inhibitors** Indication? Mechanism of action? Side effects & contraindications? Kinetic considerations?
**Alpha-glucosidase inhibitors** Reduction of post-prandial hyperglycemia. Inhibit enteric enzymes to reduce carbohydrate absorption GI symptoms (diarrhea, flatulence, bloating). Unpopular as a result. -
44
Here's some drugs, give their classes. Pioglitazone Canagliflozin Glyburide Liraglutide Sitagliptin Acarbose Meglitinide
Pioglitazone - Thiazolidinedione. Canagliflozin - SGPT-1 inhibitor. Glyburide - Sulfonylurea. Liraglutide - GLP-1 agonist. Sitagliptin - DPP-4 inhibitor. Acarbose - Alpha-glucosidase inhibitor. Meglitinide - Almost a sulfonylurea.
45
**Orlistat** Indication? Mechanism of Action? Side effects & contraindications? Kinetic considerations?
**Orlistat** Weight loss in metabolic syndrome Reversibly inhibits gastric and pancreatic lipases to reduce fat absorption. GI complaints, headache, upper respiratory infection. -